Kite Pharma to Participate in September 2016 Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc., (Nasdaq: KITE) today announced that management will participate in a panel at the 11th Annual Citi Biotech Conference and a fireside chat discussion at the Morgan Stanley Global Healthcare Conference.

A live audio webcast of each event will be available on the Investors section of Kite’s website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.

About Kite Pharma

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160831006261/en/

Kite Pharma
Greg Mann
VP, Investor Relations
[email protected]
or
For Media:
inVentiv Health
David Polk, 310-309-1029
[email protected]

Source: Kite Pharma, Inc.

You May Also Be Interested In

• Citi cuts TJX Companies rating to Neutral, lowers price target
• Metropolitan Commercial Bank Unveils New Signage at Lakewood Banking Center
• Citi cuts Lowe's price target to $260, keeps Buy rating